32
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10342 |
Antitumor agent-2
|
Others | Others |
Antitumor agent-2 具有抗炎和抗肿瘤活性,可用于研究癌症。 | |||
TPL0265 |
4-(Benzo[d]oxazol-2-yl)aniline
|
||
4-(Benzo[d]oxazol-2-yl)aniline 是一种有效的抗肿瘤剂,对乳腺癌细胞系具有抑制活性。 | |||
T3459 |
VK3-OCH3
2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na |
Others | Others |
VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) 是一种通过血红素加氧酶(HO-1) 相关机制的选择性抗肿瘤剂;维生素 K3 类似物。 | |||
T3166 |
VX-11e
Vertex-11e,VTX-11e,TCS ERK 11e |
ERK; GSK-3; FLT; CDK; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
VX-11e (TCS ERK 11e) 是可口服的ERK 高效选择性抑制剂,Ki 值小于 2 nM。 | |||
TNU0168 |
2'-Deoxy-2'-fluoro-beta-D-arabinoguanosine
|
Apoptosis | Apoptosis |
Nucleoside Derivatives - Fluoro-modified nucleosides, Arabino-nucleosides, 2’-Modified nucleosides; Drugs and Inhibitors; Anticancer agent; Impurity C of Clofarabine | |||
T11718 |
JI051
JI-051 |
Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
JI051 具有抗肿瘤作用,能够与癌症相关蛋白伴侣 prohibitin 2 (PHB2) 相互作用,通过抑制 Notch 下游效应基因 Hes1 转录来促使细胞周期停滞,抑制HEK293 细胞和胰腺癌细胞增殖。 | |||
T62814 |
Antitumor agent-77
|
||
Antitumor agent-77 对癌细胞的生长和迁移具有抑制作用,具有抗癌作用。Antitumor agent-77 能够抑制 GPx-4 和提高 COX2 引发铁下垂。Antitumor agent-77 可以激活肿瘤细胞固有凋亡通路 (Bax-Bcl-2-caspase-3),阻碍肿瘤细胞上皮间质转化 (EMT) 过程。 | |||
T63768 |
Antitumor agent-78
|
||
Antitumor agent-78 能够抑制 GPx-4 和升高 COX2 ,进而导致铁下垂 (ferroptosis)。Antitumor agent-78 可以激活肿瘤细胞固有凋亡通路 (Bax-Bcl-2-caspase-3),抑制肿瘤细胞上皮间质转化 (EMT) 过程。Antitumor agent-78 表现出抗肿瘤效果,并能够抑制癌细胞的生长和迁移。 | |||
T64022 | Antitumor agent-37 | ||
Antitumor agent-37 表现出有效的抗增殖和抗转移效果。Antitumor agent-37 能够诱导严重的 DNA 损伤,进而导致 γ-H2AX 和 p53 的高表达。Antitumor agent-37 可利用线粒体凋亡通路 Bcl-2/Bax/caspase3,诱导肿瘤细胞凋亡 (apoptosis)。Antitumor agent-37 可以抑制 PD-L1 的表达,提高肿瘤组织中 CD3+ 和 CD8+ T 浸润细胞,明显改善免疫反应。 | |||
T14879 | CB 300919 | Others | Others |
CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM). | |||
T28411 |
Physapubenolide
NSC 368674,NSC368674,NSC-368674 |
||
Physapubenolide is natural cytotoxic withanolide antitumor agent. Physapubenolide induces apoptosis by decreasing mitochondrial membrane potential and elevating the Bax/Bcl-2 protein expression ratio. | |||
T15180 |
Duocarmycin A
|
Caspase | Apoptosis; Proteases/Proteasome |
Duocarmycin A, an antitumor antibiotic, is a DNA alkylator and efficiently alkylates adenine N3 at the 3′ end of AT-rich sequences in the DNA. Duocarmycin A, as a chemotherapeutic agent, results in HLC-2 cells typically apoptotic changes. | |||
T63523 |
Duocarmycin analog-2
|
||
Duocarmycin analog-2 是有效的 DNA 烷基化剂,表现出抗肿瘤作用,能够用于免疫偶联物的合成。 | |||
T12925 |
Sitravatinib malate
MGCD516 malate,MG-516 malate |
TAM Receptor | Tyrosine Kinase/Adaptors |
Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.) , shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment. | |||
T61996 |
Antiproliferative agent-6
|
||
Antiproliferative agent-6 (compound 8a) 是有效的抗肿瘤化合物。Antiproliferative agent-6 具有抗增殖活性,抑制癌细胞系 HCT116、MCF-7、H460 和非肿瘤非整倍体永生角质细胞 HaCaT 的 GI50分别为 0.5 μM、2 μM、0.7 μM 和 3.5 μM。 | |||
T75667 |
Neamine
|
||
Neamine,新霉素降解产物,为广谱氨基糖苷类抗生素。作为抗血管生成剂,针对血管生成素 (angiogenin),展现抗菌、抗肿瘤及神经保护活性。 | |||
T83008 |
Antitumor agent-119
|
||
Antitumor agent-119(化合物13K)为2-苯并恶唑基腙衍生物,显示抗癌活性。该化合物对Butkitt、CCRF-CEM、HeLa和HT-29细胞系展现出细胞生长抑制作用,其IC50值分别为30 nM、140 nM、100 nM和40 nM。 | |||
T81835 |
MC-betaglucuronide-MMAE-2
|
||
MC-betaglucuronide-MMAE-2 是由微管蛋白聚合抑制剂 MMAE 与 ADC linker MC-betaglucuronide 可降解连接组成的抗体-活性分子偶联物部分。 | |||
T74393 | Antitumor agent-36 | ||
Antitumor agent-36 具有有效的抗增殖和抗转移活性,能诱导严重的 DNA 损伤,并通过增加 γ-H2AX 和 p53 的表达促进肿瘤细胞通过 Bcl-2/Bax/caspase3 线粒体凋亡通路的 (apoptosis)。此外,Antitumor agent-36 还能通过抑制 PD-L1 的表达显著增加肿瘤组织中 CD3+ 和 CD8+ T 浸润细胞,从而改善免疫反应。 | |||
T79111 | PI3Kγ inhibitor 7 | PI3K | PI3K/Akt/mTOR signaling |
PI3Kγ inhibitor7(compound 2)作为一种有效的PI3Kγ抑制剂,拥有口服活性,并对PI3Kα、PI3Kβ、PI3Kγ、PI3Kδ的抑制作用,其IC50值分别为4768 nM、878.1 nM、3.42 nM、355.2 nM。此外,PI3Kγ inhibitor7还展现出了抗肿瘤活性。 | |||
T76940 |
Cantuzumab ravtansine
|
||
Cantuzumab ravtansine (IMGN242; huC242-DM4) 是一种 ADC,由一种人源化单克隆抗体 huC242,通过二硫键与 DM4 (DM4) 共价连接。Cantuzumab ravtansine 对一系列 CanAg 阳性人肿瘤异种移植物具有广泛的抗肿瘤功效。 | |||
T9684 |
(Z)-Orantinib
|
||
(Z)-Orantinib ((Z)-SU6668) 是一种有效,选择性,具有口服活性和 ATP 竞争性的 Flk‐1/KDR,PDGFRβ和 FGFR1抑制剂,IC50值分别为 2.1,0.008 和 1.2 μM。(Z)-Orantinib 是有效的抗血管生成和抗肿瘤剂,可诱导已形成的肿瘤消退。 | |||
T35645 |
4-oxo Cyclophosphamide
|
||
4-oxo Cyclophosphamide is an inactive metabolite of the alkylating agent cyclophosphamide .1,2It is formed from cyclophosphamide through a 4-hydroxycyclophosphamide intermediate by aldehyde dehydrogenases.2 1.Struck, R.F., Kirk, M.C., Mellett, L.B., et al.Urinary metabolites of the antitumor agent cyclophosphamideMol. Pharmacol.7(5)519-529(1971) 2.de Jonge, M.E., Huitema, A.D.R., Rodenhuis, S., et al.Clinical pharmacokinetics of cyclophosphamideClin. Pharmacokinet.44(11)1135-1164(2005) | |||
T62479 |
3CPLro-IN-1
|
||
3CPLro-IN-1 (compound A17) 是一种有效的、口服具有活力的 SARS-CoV-2 3CLpro 抑制剂 (IC50: 5.65 μM)。3-糜蛋白酶样半胱氨酸蛋白酶 (3CLpro) 是一种病毒复制中不可或缺的蛋白质,是一种有吸引力的、对抗 COVID-19 的药物靶点。 | |||
T68400 |
STA-9584
|
||
STA-9584 is a potent vascular disrupting agent, which exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumors. In vitro, 2-methoxy-5-(5-(3,4,5-trimethoxyphenyl)isoxazol-4-yl)aniline (STA-9122) (active metabolite of STA-9584 ) displayed increased potency relative to other tubulin-binding agents and was highly cytotoxic to tumor cells. STA-9584 induced significant tumor regressions in prostate and breast xenograft models in vivo and, ... | |||
T60704 |
Loxoprofen sodium (dihydrate)
|
||
Loxoprofen sodium dihydrate 是一种非甾体类口服抗炎药,具有镇痛和解热作用。Loxoprofen sodium dihydrate 显示出抗肿瘤活性,并且可减少动脉粥样硬化。Loxoprofen sodium dihydrate 是COX 的非选择性抑制剂,对 COX-1 和 COX-2 的IC50值分别为 6.5 和 13.5 μM。 | |||
T80523 |
Azurin p28 peptide
|
||
Azurin p28 peptide是一种具有肿瘤穿透能力和抗肿瘤活性的肽。它通过与p53结合形成p28:p53复合物,从而降低p53在蛋白酶体中的降解,进而诱导细胞凋亡(apoptosis)或使细胞周期停滞。此外,Azurin p28 peptide通过抑制VEGFR-2、FAK和Akt的磷酸化表现出抗血管生成效果,抑制p53阳性肿瘤的生长。 | |||
T36745 |
cDPCP
|
||
cDPCP is a platinum-containing DNA-crosslinking agent.1Unlike cisplatin or oxaliplatin , cDPCP forms monofunctional DNA adducts. It is transported into cells by organic cation transporter 1 (OCT1) and OCT2, inhibiting proliferation of MDCK cells expressing the human transporters with IC50values of 8.1 and 1.5 μM, respectively. cDPCP inhibits RNA polymerase II-mediated transcription in a reporter assay using HeLa cells. It increases survival in murine S180 sarcoma and P388 leukemia models when ad... | |||
T74546 |
FAP-2286
|
||
FAP-2286,一种与放射性核素螯合剂 DOTA 偶联的 FAP 结合肽大环化合物。FAP-2286 对人 FAP 蛋白具有强亲和力,Kd 为 1.1 nM。FAP-2286 具有抗肿瘤活性。FAP-2286 可用放射性核素标记,用于治疗及诊断。 | |||
T36967 |
LSN3106729 hydrochloride
|
||
LSN3106729 hydrochloride, the metabolite of Abemaciclib , is a CDK inhibitor with antitumor activity. LSN3106729 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1]. [1]. Edward S. Kim, et al. Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study. [2]. Nathanael Gray, et al. Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods o... | |||
T63769 |
EGFR-IN-60
|
||
EGFR-IN-60 是一种有效的、口服具有活力的、安全的抗肿瘤剂。EGFR-IN-60 能够明显抑制 EGFRWT (IC50: 83 nM)、EGFRT790M (IC50: 26 nM)、EGFRL858R (IC50: 53 nM) 和 JAK3 (IC50: 69 nM)。EGFR-IN-60 能够抑制携带 EGFRT790M 突变的 H1975 细胞 (IC50: 1.32 μM) ,并抑制过表达 EGFRWT 的 A431 细胞 (IC50: 4.96 μM)。EGFR-IN-60 能够提高 Bax/Bcl-2 比率,进而诱导细胞凋亡诱导并导致细胞死亡。 | |||
T71261 | Arsthinol | ||
Arsthinol is an antiprotozoal agent which may have anti-cancer activity. It was found that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD50/IC50. Arsthinol induced growth inhibition of NB4 cells at lower concentration (IC50 (concentration inhibiting growth by 50%) = 0.78 +/- 0.08 micromol/l after 24 h) than As(2)O(3) (IC50 = 1.60 +/- 0.23 micro... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1257 |
Bestatin
Ubenimex,乌苯美司 |
Others; Aminopeptidase; Antibacterial; Antibiotic; LTR | Immunology/Inflammation; Metabolism; Microbiology/Virology; Others |
Bestatin (Ubenimex) 是 CD13 (Aminopeptidase N)/APN 和 leukotriene A4 hydrolase 抑制剂,可用于癌症研究。 | |||
T75563 | Vanicoside E | ||
Vanicoside E 是一种抗氧化和抗癌剂。Vanicoside E 抑制L-Tyrosine 和L-DOPA,IC50为 45.23 μM 和 189.96 μM。 | |||
T14121 |
Actinonin
(-)-Actinonin |
Aminopeptidase | Metabolism |
Actinonin ((-)-Actinonin) is a naturally occurring antibacterial agent produced by Actinomyces and a potent reversible peptide deformylase (PDF) inhibitor with a Ki of 0.28 nM, it also is an apoptosis inducer. Actinonin inhibits aminopeptidase M, aminopeptidase N and leucine aminopeptidase, it also inhibits MMP-1, MMP-3, MMP-8, MMP-9, and hmeprin α with Ki values of 300 nM, 1,700 nM, 190 nM, 330 nM, and 20 nM, respectively. Actinonin has antiproliferative and antitumor activities[1][2][3][4][5]. | |||
T81170 |
Shishijimicin A
|
||
Shishijimicin A是一款从子囊菌Didemnum proliferum中分离出的新型抗肿瘤剂,具备突出的细胞毒性及抗肿瘤活性。作为点击化学试剂,Shishijimicin A内含Alkyne基团,能够与含Azide基团的分子通过铜催化的叠氮-炔环加成反应(CuAAc)进行作用。 |